Leadless pacemakers market is forecasted to value over US$ 260 million by the end of 2026 and growing at a CAGR of over 21%during the forecast period, 2019 to 2026.
Leadless pacemakers are medical devices which are used for the treatment of patients suffering from cardiac problems such as arrhythmias. These are complete enclosed capsules which include pacemakers and electronic source. Further, leadless pacemakers are implantable devices transplanted directly in the right ventricle of the heart where it sends small electrical impulses to the heart muscles to continue at an acceptable heart rate. Additionally, leadless pacemakers are less invasive as compared to traditional pacemakers and can be implanted within an hour. Leadless pacemakers take less time to recover and also eliminate problems related to trans-venous leads such as lead fracture, insulation breaks and other. Leadless pacemakers produce comparatively less radiation and have better life quality without causing any infection to the heart ventricle.
According to World Society of Arrhythmia, over one million of cardiac pacemakers are implanted every year. Market is majorly driven by rising geriatric population and increasing prevalence of heart diseases. Along with this, technological evolution led to rapid advancement of pacemakers. It improved the safety & efficacy of the pacemakers and improved the management of arrhythmias. Leadless pacing reduces complication of transvenous pacemaker procedure and increased the success rate disease management. Further, increasing importance of leadless pacemakers over traditional methods led to potential growth of the market. Further, increasing government support and changing demographics of general population fuelled the growth of the market.
Global market is dominated by North America due to high adoption of leadless pacemakers. In North America, US dominated the market and it accounts more 90% of the market share during forecast period. Europe market is majorly dominated by UK, Germany and France due to high penetration among the end user segment. Asia Pacific is expected to create new opportunities for manufacturers due to increasing adoption. It is majorly dominated by Japan, China & India and it is expected to register highest growth rate. It is followed by Latin America and it dominated by Brazil and Mexico. Rest of the world accounts small fraction of global market share due to less adoption.
Leadless Pacemakers market players include Medtronic, Abbott and others. Market is majorly dominated by few players and market is expected to witness new entries during forecast period.
Request a Sample Report https://www.futurewiseresearch.com/request-sample.aspx?id=202&page=requestsample
Leadless Pacemakers Market Segmentation
By Indication
+ Atrial Fibrillation
+ High Degree Atrioventricular Block
+ Sinus node dysfunction
By End User
+ Hospitals
+ Catheterization Laboratories
By Region
+ North America
+ Latin America
+ Europe
+ Asia Pacific
+ Rest of the World
Purchase a Copy of this Premium Research Report & Ask for Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=202&page=askfordiscount
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
FutureWise Key Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global Leadless Pacemakers Market by Indication, by End-User, by Region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Table of Contents
1.1. Introduction
1.1.1.1. Scope and Objective
1.1.1.2. Assumptions and Acronyms
1.1.1.3. Forecast Factors
1.1.1.4. Research Methodology
1.2. Executive Summary
1.2.1.1. Industry Cluster Analysis
1.2.1.2. Competition Matrix
1.2.1.3. Strategies Recommendations
1.3. Market Definition
1.3.1.1. Report Scope (Inclusions & Exclusions)
1.3.1.2. Market Segmentation
1.4. Global Leadless Pacemakers Market Overview
1.4.1.1. Global Leadless Pacemakers Market Revenue (USD Mn)
1.5. Key Inclusions
1.5.1.1. Porter’s Five Force analysis
1.5.1.2. Market Dynamics
1.5.1.3. Industry Trends
1.5.1.4. Regulatory Guidelines
1.5.1.5. Opportunities in Leadless Pacemakers
1.6. Competition Dynamics
1.6.1.1. Company Share Analysis (2018)
1.6.1.2. Top 10 Product Pricing by Region
1.7. Global Leadless Pacemakers Market Revenue (USD Mn), 2018-2026 by Indication
1.7.1.1. Key Market Findings
1.7.1.2. Long Term ROI Segments
1.7.1.3. Revenue Opportunity Influencing Factors
1.7.1.4. Market Revenue (USD Mn) Assessment and Forecast by Indication, 2018-2026
1.7.1.4.1.1. Atrial Fibrillation
1.7.1.4.1.2. High Degree Atrioventricular Block
1.7.1.4.1.3. Sinus node dysfunction
1.8. Global Leadless Pacemakers Market Revenue (USD Mn), 2018-2026 by End User
1.8.1.1. Key Market Findings
1.8.1.2. Long Term ROI Segments
1.8.1.3. Revenue Opportunity Influencing Factors
1.8.1.4. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
1.8.1.4.1.1. Hospitals
1.8.1.4.1.2. Catheterization Laboratories
1.9. Global Leadless Pacemakers Market Revenue (USD Mn), 2018-2026 by Region
1.9.1.1. Key Market Findings
1.9.1.2. Long Term ROI Segments
1.9.1.3. Revenue Opportunity Influencing Factors
1.9.1.4. Market Revenue (USD Mn) Assessment and Forecast by Region,2026
1.9.1.4.1.1. North America
1.9.1.4.1.2. Latin America
1.9.1.4.1.3. Europe
1.9.1.4.1.4. Asia Pacific
1.9.1.4.1.5. Rest of world
1.10. North America Leadless Pacemakers Market Revenue (US$ Mn), 2018-2026
1.10.1.1. Key Market Findings
1.10.1.2. Long Term ROI Segments
1.10.1.3. Revenue Opportunity Influencing Factors
1.10.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
1.10.1.4.1.1. US
1.10.1.4.1.2. Canada
1.10.1.5. Market Revenue (USD Mn) Assessment and Forecast by Indication, 2018-2026
1.10.1.5.1.1. Atrial Fibrillation
1.10.1.5.1.2. High Degree Atrioventricular Block
1.10.1.5.1.3. Sinus node dysfunction
1.10.1.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
1.10.1.6.1.1. Hospitals
1.10.1.6.1.2. Catheterization Laboratories
1.11. Latin America Leadless Pacemakers Market Revenue (US$ Mn), 2018-2026
1.11.1.1. Key Market Findings
1.11.1.2. Long Term ROI Segments
1.11.1.3. Revenue Opportunity Influencing Factors
1.11.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
1.11.1.4.1.1. Brazil
1.11.1.4.1.2. Mexico
1.11.1.4.1.3. Argentina
1.11.1.4.1.4. Rest of Latin America
1.11.1.5. Market Revenue (USD Mn) Assessment and Forecast by Indication, 2018-2026
1.11.1.5.1.1. Atrial Fibrillation
1.11.1.5.1.2. High Degree Atrioventricular Block
1.11.1.5.1.3. Sinus node dysfunction
1.11.1.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
1.11.1.6.1.1. Hospitals
1.11.1.6.1.2. Catheterization Laboratories
1.12. Europe America Leadless Pacemakers Market Revenue (US$ Mn), 2018-2026
1.12.1.1. Key Market Findings
1.12.1.2. Long Term ROI Segments
1.12.1.3. Revenue Opportunity Influencing Factors
1.12.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
1.12.1.4.1.1. Germany
1.12.1.4.1.2. France
1.12.1.4.1.3. Spain
1.12.1.4.1.4. UK
1.12.1.4.1.5. Russia
1.12.1.4.1.6. Poland
1.12.1.4.1.7. Rest of Europe
1.12.1.5. Market Revenue (USD Mn) Assessment and Forecast by Indication, 2018-2026
1.12.1.5.1.1. Atrial Fibrillation
1.12.1.5.1.2. High Degree Atrioventricular Block
1.12.1.5.1.2.1. Sinus node dysfunction
1.12.1.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
1.12.1.6.1.1.1. Hospitals
1.12.1.6.1.1.2. Catheterization Laboratories
1.13. Asia Pacific America Leadless Pacemakers Market Revenue (US$ Mn), 2018-2026
1.13.1.1. Key Market Findings
1.13.1.2. Long Term ROI Segments
1.13.1.3. Revenue Opportunity Influencing Factors
1.13.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
1.13.1.4.1.1. Emerging Asia
1.13.1.4.1.1.1.1. China
1.13.1.4.1.1.1.2. India
1.13.1.4.1.1.1.3. ASEAN-5
1.13.1.4.1.1.1.4. Rest of Emerging Asia
1.13.1.4.1.2. Japan
1.13.1.5. Market Revenue (USD Mn) Assessment and Forecast by Indication, 2018-2026
1.13.1.5.1.1. Atrial Fibrillation
1.13.1.5.1.2. High Degree Atrioventricular Block
1.13.1.5.1.3. Sinus node dysfunction
1.13.1.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
1.13.1.6.1.1. Hospitals
1.13.1.6.1.2. Catheterization Laboratories
1.14. Rest of World America Leadless Pacemakers Market Revenue (US$ Mn), 2018-2026
1.14.1.1. Key Market Findings
1.14.1.2. Long Term ROI Segments
1.14.1.3. Revenue Opportunity Influencing Factors
1.14.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
1.14.1.4.1.1. Middle East
1.14.1.4.1.2. South Africa
1.14.1.4.1.3. North Africa
1.14.1.4.1.4. Rest of World
1.14.1.5. Market Revenue (USD Mn) Assessment and Forecast by Indication, 2018-2026
1.14.1.5.1.1. Atrial Fibrillation
1.14.1.5.1.2. High Degree Atrioventricular Block
1.14.1.5.1.3. Sinus node dysfunction
1.14.1.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
1.14.1.6.1.1. Hospitals
1.14.1.6.1.2. Catheterization Laboratories
1.15. Company Profiles
1.15.1.1. Competition Landscape
1.15.1.2. Global Company Share (USD Mn) Overview, 2018
1.15.1.3. Company Profiles
1.15.1.3.1.1. Medtronic
1.15.1.3.1.1.1.1. Corporate Overview
1.15.1.3.1.1.1.2. Financial Performance
1.15.1.3.1.1.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.1.1.4. Company Strategy & Channel Management
1.15.1.3.1.2. Abbott
1.15.1.3.1.2.1.1. Corporate Overview
1.15.1.3.1.2.1.2. Financial Performance
1.15.1.3.1.2.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.2.1.4. Company Strategy & Channel Management
1.15.1.3.1.3. Others
1.15.1.3.1.3.1.1. Corporate Overview
1.15.1.3.1.3.1.2. Financial Performance
1.15.1.3.1.3.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.3.1.4. Company Strategy & Channel Management
1.16. Research Sources & Primary Verbatim
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com